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Conclusion: the incidence of BC is still low in Africa compared to the incidence in Europe. 
This has largely been attributed to a protective reproductive history including late menarche, early 
menopause, high parity with prolonged breastfeeding. However, African women tend to present at an 
earlier age and the disease appears to be more aggressive than in their European counterparts. 
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Sumy regional oncological dyspancer 
Pigmented nevi are benign proliferations present at birth that consists of cells normally present 
in skin. Some nevi have a malignant potential. There is a lot of methods of treatment of this abnormal 
condition, namely surgical resection, cryosurgery, laser excision, the use of bleaching agents. Surgical 
method not impeded the spread of  nevi cells, what has the potential for malignancy. Non contact 
mode of excision with laser can reduce intraroperative wound contamination by tumor cells. For its 
universal properties the carbon dioxide (CO2) laser appears to be an excellent surgical instrument in 
oncologic surgery of skin lesions. 
Aim: To improve results of surgical treatment of congenital pigmented nevi by using CO2 
laser. 
Materials and methods: CO2 laser was used in treatment of 50 patients with pigmented 
nevus consisting of 24 (48%) males and 26 (52%) females with age ranges from 16 - 68 years. For 
local anesthesia 0,5% Sol. lidocaine was used The treatment effect was based on the surgical wound 
evaluation, the relative time of healing and possible local recurrence of the tumor after 3 months after 
surgery. 
Results: excision was made in 20 (40%) cases of nevi greater than1.5 cm diameter, and 30 
(60%) patients of nevi  ranging from 0.5 to 1.5 cm in diameter. In all patients, whom CO2 laser was 
used for excision of pigmented nevi, bleeding was absent during operation, injury of surrounding 
tissues was minimal and healing of wound was during 7-14 days, without infection complications. 
Improved visibility through better hemostasis provides greater confidence of complete excision and 
time saving. In 34 (68%) cases time needed for complete resection of lesions was less than 10 minutes. 
Time of healing was longer than 12 days in 8 cases (16,0%) . Local recurrence was observed only in 
two cases (4%). The probable cause of this  is the sealing of small blood vessels and lymph vessels 
by the CO2 laser which prevents tumor cells spreading. The advantages of the CO2 laser surgery 
were better hemostasis, precision of working, non-contact dissection (absence of the potential for 
malignancy), minimum traumatization of the surrounding tissues, reduced postoperative pain,  quick 
postoperative healing .  
Conclusion:  CO2 laser is an effective method of surgical treatment of congenital pigmented 
nevi. 
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Colorectal carcinoma (CRC) is the third most common cancer worldwide and the third most 
common cause of deaths from cancer in both sexes in industrialized nations. The incidence varies 
according to geographical location with the highest rates reported from Northern and Western Europe, 
USA.  The incidence of CRC in USA reaches 57,0 per 100 000 population, in Ukraine, according to 
the National Cancer Registry in 2013 was 44,0 per 100 000 population, in the Sumy region, this date 
was 43,1/100 000. Although the highest incidence of CRC in USA is seen among African Americans 
(71,0/100 000) , CRC is an uncommon malignancy in Nigeria. Studies that have been published from 
